Dried Blood Spot Card vs. Mitra Microsampling Device
When Dried Blood Spot (DBS) cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation. But adoption has been hindered by regulatory concerns over the "Hematocrit (HCT) Effect," along with their automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.
The FDA Class 1 Mitra® Microsampler is a novel specimen collection device that retains the advantages of Dried Blood Spot cards and solves for their limitations.
Powered by Volumetric Absorbtive Microsampling Technology (VAMS™), it provides an efficient, economical, and volumetrically accurate Dried Blood Spot alternative that's easy to implement and geared toward the future, especially for remote sampling.